Looking for approved-medicines to be repositioned as anti-Trypanosoma cruzi agents. Identification of new chemotypes with good individual- or in combination-biological behaviours
BACKGROUND The neglected illness Chagas disease is treated with limited efficacy and adverse effects by old drugs. Due to the low interest of pharmaceutical industry in targeting economically depressed-patients, repurposing is a tool that should be applied because it can introduce new anti-Chagas en...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , |
| Format: | article |
| Language: | English |
| Published: |
2025
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/20.500.12008/53058 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Looking for approved-medicines to be repositioned as anti-Trypanosoma cruzi agents. Identification of new chemotypes with good individual- or in combination-biological behaviours
- Looking for combination of benznidazole and trypanosoma cruzitriosephosphate isomerase inhibitors for chagas disease treatment
- Characterization of controlled trials on probiotic supplementation to dairy calves: A scoping review.
- Formation of protein-derived electrophiles in ribonuclease a by biologically relevant oxidants
- Environmental variables, habitat discontinuity and life history shaping the genetic structure of Pomatoschistus marmoratus
- The person, supreme good of the right: A look at the evolution of the protection of the person in the Spanish law
- Dietary chia meal and hydroxytyrosol outcomes in broiler performance, lipid blood serum parameters and meat quality.